Related Experiment Videos
Radionuclide studies in surgical oncology
1Department of Nuclear Medicine, Singapore General Hospital.
Annals of the Academy of Medicine, Singapore
|January 1, 1988
Summary
Radionuclides are vital for tumor diagnosis and treatment, offering insights into tumor morphology and function. Advances in imaging technologies like PET and SPECT, alongside radiolabeled antibodies, enhance these capabilities.
Area of Science:
- Nuclear medicine
- Oncology
- Medical imaging
Background:
- Radionuclides have been utilized for over 40 years in cancer diagnosis and therapy.
- Tumor imaging and treatment have significantly benefited from advancements in nuclear medicine.
Purpose of the Study:
- To review the evolving role of radionuclides in oncology.
- To highlight advancements in imaging techniques and radiopharmaceuticals.
- To discuss the application of radiolabeled antibodies and tumor markers.
Main Methods:
- Radionuclide scintigraphy for tumor morphology and function assessment.
- Advanced imaging modalities including digital gamma-cameras, SPECT, and PET.
- Use of radiolabeled antibodies for immunoscintigraphy and immunotherapy.
- In vitro tumor marker testing.
Main Results:
- Radionuclide scintigraphy provides crucial functional and morphological data on tumors.
- Technological advancements have improved the precision and utility of radionuclide imaging.
- Radiolabeled antibodies show significant promise in immunoscintigraphy and immunotherapy.
- In vitro tumor marker tests are expected to play an increasing role.
Conclusions:
- Radionuclides are indispensable tools in modern oncology.
- Continuous innovation in instrumentation and radiopharmaceuticals expands their clinical applications.
- Immunoscintigraphy, immunotherapy, and tumor marker tests represent key future directions.